Clinical evidence for caspofungin monotherapy in the first-line and salvage therapy of invasive Aspergillus infections.

Heinz, Werner J; Buchheidt, Dieter; Ullmann, Andrew J

Heinz, Werner J; Buchheidt, Dieter; Ullmann, Andrew J.

Affiliation

Heinz WJ; Medizinische Klinik and Poliklinik II, Infectious Diseases University of Würzburg Medical Center, Würzburg, Germany.
Buchheidt D; Department of Hematology and Oncology, Mannheim University Hospital, University of Heidelberg, Mannheim, Germany.
Ullmann AJ; Medizinische Klinik and Poliklinik II, Infectious Diseases University of Würzburg Medical Center, Würzburg, Germany.

Mycoses ; 59(8): 480-93, 2016 Aug.

Article in En | MEDLINE | ID: mdl-27324802

Subject(s)

Aspergillosis/drug therapy; Echinocandins/therapeutic use; Invasive Fungal Infections/drug therapy; Lipopeptides/therapeutic use; Salvage Therapy/methods; Antifungal Agents/therapeutic use; Aspergillosis/microbiology; Caspofungin; Clinical Trials as Topic; Echinocandins/administration & dosage; Echinocandins/adverse effects; Humans; Invasive Fungal Infections/microbiology; Lipopeptides/administration & dosage; Lipopeptides/adverse effects; Prospective Studies; Treatment Outcome

Key words

Aspergillosis; Aspergillus; antifungal agents; invasive fungal infection

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Aspergillosis / Salvage Therapy / Echinocandins / Lipopeptides / Invasive Fungal Infections Type of study: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: Mycoses Journal subject: MICROBIOLOGIA Year: 2016 Type: Article Affiliation country: Germany

Fulltext

XML

PubMed Links

Search on Google